Home / About Barrow Neurological Institute / News & Articles / As Seen In / Barrow Awarded $5M for Ibogaine Clinical Trial in TBI
Barrow Awarded $5M for Ibogaine Clinical Trial in TBI
Barrow Neurological Institute has received a $5 million grant from the Arizona Department of Health Services to study ibogaine treatment in people with neurological disorders such as traumatic brain injury (TBI).
Related Coverage:
- American Association for the Advancement of Science: Barrow Neurological Institute Awarded $5-million for Clinical Trial of Ibogaine in TBI
- Health Tech World: University awarded US $5 million for Clinical Trial of Ibogaine in TBI
- Bioengineer: Barrow Institute Receives $5 Million for Ibogaine Traumatic Brain Injury Trial
- Medical Daily: Arizona Is Paying $5 Million for an Ibogaine Trial in Brain Injury
- KTAR News: Barrow Neurological Institute gets $5M Arizona Health Grant for Brain Injury Drug Trial
- KJZZ Phoenix: Arizona Awards $5 million Grant to Barrow Neurological Institute to Study Ibogaine for Brain Injuries